Variant report
Variant | nsv600999 |
---|---|
Chromosome Location | chr6:14839778-14841092 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6939905 | chr6:14839778-14839779 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs541324963 | chr6:14839792-14839793 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs370822641 | chr6:14839795-14839796 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs182640157 | chr6:14839882-14839883 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs9476668 | chr6:14839995-14839996 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs187099210 | chr6:14840016-14840017 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs2031298 | chr6:14840050-14840051 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs192848737 | chr6:14840082-14840083 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs9396535 | chr6:14840185-14840186 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs542662366 | chr6:14840250-14840251 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs183482592 | chr6:14840254-14840255 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs151150048 | chr6:14840257-14840258 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs554728061 | chr6:14840268-14840269 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs577816480 | chr6:14840281-14840282 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs141123925 | chr6:14840301-14840302 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs188639443 | chr6:14840408-14840409 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs576730521 | chr6:14840412-14840413 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs543623197 | chr6:14840421-14840422 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs193139790 | chr6:14840427-14840428 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs371377437 | chr6:14840437-14840438 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs185614309 | chr6:14840440-14840441 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs541197977 | chr6:14840461-14840462 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs188385057 | chr6:14840470-14840471 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs146932423 | chr6:14840493-14840494 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs62390283 | chr6:14840507-14840508 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs34192416 | chr6:14840535-14840536 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs75882538 | chr6:14840552-14840553 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs532868963 | chr6:14840597-14840598 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs529014211 | chr6:14840602-14840603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs138081100 | chr6:14840613-14840614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs191511707 | chr6:14840655-14840656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs62390284 | chr6:14840657-14840658 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs183665908 | chr6:14840665-14840666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs559395194 | chr6:14840725-14840726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs568242123 | chr6:14840756-14840757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs188708790 | chr6:14840760-14840761 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs368841417 | chr6:14840772-14840773 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs11438086 | chr6:14840773-14840774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs74724848 | chr6:14840785-14840786 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs397796117 | chr6:14840786-14840787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs181096906 | chr6:14840804-14840805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs570380340 | chr6:14840815-14840816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs528035229 | chr6:14840838-14840839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs539370763 | chr6:14840859-14840860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs558890233 | chr6:14840866-14840867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs375354226 | chr6:14840873-14840874 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs186970655 | chr6:14840888-14840889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs149120157 | chr6:14840921-14840922 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs574991513 | chr6:14840922-14840923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs373587407 | chr6:14840937-14840938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Bladder cancer | 21909424 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 16790693 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:14832200-14855400 | Weak transcription | H9 Cell Line | embryonic stem cell |
2 | chr6:14836600-14840200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
3 | chr6:14837000-14839800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr6:14837800-14839800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr6:14838200-14841800 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
6 | chr6:14838400-14839800 | Enhancers | Fetal Muscle Leg | muscle |
7 | chr6:14838400-14841800 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
8 | chr6:14838600-14839800 | Weak transcription | Fetal Kidney | kidney |
9 | chr6:14838600-14842200 | Weak transcription | Fetal Stomach | stomach |
10 | chr6:14838600-14842400 | Weak transcription | Rectal Smooth Muscle | rectum |
11 | chr6:14838800-14839800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
12 | chr6:14839000-14841800 | Weak transcription | NHDF-Ad | bronchial |
13 | chr6:14839200-14842000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
14 | chr6:14839400-14840600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
15 | chr6:14839600-14842000 | Weak transcription | Primary monocytes fromperipheralblood | blood |
16 | chr6:14839600-14842200 | Weak transcription | Colon Smooth Muscle | Colon |
17 | chr6:14839600-14842200 | Weak transcription | Fetal Lung | lung |
18 | chr6:14839600-14844800 | Weak transcription | Ovary | ovary |
19 | chr6:14839600-14849400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
20 | chr6:14839800-14840000 | Enhancers | Fetal Kidney | kidney |
21 | chr6:14840000-14840600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
22 | chr6:14840600-14843800 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |